Swiss Anti-Aging Treatment Gives the Elderly Healthier Muscles

An anti-aging dietary supplement developed by the Swiss biotech Amazentis to combat age-related muscle weakening has improved the health of muscle cells in a first-in-human study. Mitochondria are parts of the cell that generate energy,...

Hypertension Drug Improves Blood Flow in Memory Center of Alzheimer’s Disease Brain

Researchers in the Netherlands have found that a common blood pressure drug can boost blood flow to the learning and memory center of the brain in patients with Alzheimer’s disease (AD). Previous studies have suggested...

The complex fate of Antarctic species in the face of a changing climate

Credit: Simon Morley Oxygen concentrations in both the open ocean and coastal waters have declined by 2-5% since at least the middle of the 20th century. This is...

Global Triage Meterpro Market Analysis 2019 Beijing nine strong Biotechnology, Response Biomedical Corporation, Wallac...

Our reports have a realistic aspect attached to it due to some of the finely tuned realistic concept mentioned in a simple and plain manner. The “Triage Meterpro” market research report mentioned on our...

New natural extract inhibits the development of diabetic nephropathy

A team of researchers have published in the Journal of Cellular Physiology that a new natural extract is able to inhibit the development of diabetic nephropathy, a kidney disease that is increasing in incidence...

High tunnels for specialty crops: The hope and the hinderance

Study gains a better understanding, from the perspective of farmers, of the challenges and advantageous opportunities associated with using high tunnels for specialty crops Credit: Full Hand Farm

Snack peppers find acceptance with reduced seed count

Study investigates the desirability for, and practicality of, producing snack peppers, both sweet and hot, with low seed count Credit: John Stommel John Stommel of the Agricultural Research Service of the US Department of Agriculture (USDA-ARS)...

First Gene Therapy for Beta Thalassemia Will Cost Over €1.5M

Zynteglo, a gene therapy developed by the US company bluebird bio for the treatment of beta-thalassemia, will cost European healthcare systems more than €1.5M per patient. Following the approval of the treatment earlier this month,...

Thermo Fisher’s Brammer Bio Completing $100M in Expansion Projects

Thermo Fisher Scientific says its recently-acquired Brammer Bio is completing $100 million in capital expansion projects, as the viral vector contract development and manufacturing organization (CDMO) looks to satisfy growing demand for gene therapies...

Novel Technique Shows How Proteins Move out of E. Coli Cells

Scientists at the University of Missouri (MU), who report that they used a new approach to discover how proteins leave the inside of an E. coli cell, say their finding could have important implications...

Stay connected

44,968FollowersFollow
14,700SubscribersSubscribe

Recent posts

Random article